This post was originally published on this site My family and I stopped to look at art this week. While we wandered among sculptures, someone smashed the window of our truck and stole our stuff: all three passports, two cameras, and lots of clothes. Most devastatingly, though, they got my laptop. The book I’ve been…
This post was originally published on this site Caring for a loved one as they battle dual terminal illnesses can be overwhelming, an experience filled with sadness, so I was thrilled when my aunt said that she was coming to town to visit for the weekend. I imagined the two sisters bonding over old memories…
This post was originally published on this site Maintenance therapy with Ninlaro (ixazomib) can prolong and boost therapeutic responses from initial treatment in multiple myeloma patients who did not undergo an autologous stem cell transplant, a study says. The study, “Ixazomib maintenance therapy in newly diagnosed multiple myeloma: An integrated analysis of four phase I/II studies,” was…
This post was originally published on this site GlycoMimetics is planning a clinical trial testing its therapy candidate GMI-1359 as a treatment for breast cancer patients whose tumors have spread to the bones, the company announced. GMI-1359 is a small molecule that simultaneously targets E-selectin and CXCR4, two adhesion molecules — cell surface proteins that…
This post was originally published on this site Blood levels of a nerve cell-derived component, known as neurofilament light chain, could be used as a biomarker of disease severity and treatment response in patients with Alzheimer’s disease, a study suggests. The study, ”Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer’s Disease,”…
This post was originally published on this site A large-scale screening provided a system to prioritize gene targets for the potential development of tailored cancer therapies. According to the scientists, the findings may also help produce the Cancer Dependency Map, a comprehensive rulebook for the precision treatment of cancer. The study, “Prioritisation of cancer therapeutic…
This post was originally published on this site Using an advanced microscopic technique to visualize how CAR T cells work in a mouse model of lymphoma, researchers found that these cells can induce tumor regression by directly targeting and killing cancer cells but there is significant diversity in how they behave in an animal. The study,…
This post was originally published on this site PureTech Health is developing two promising candidate therapies that target key immunosuppressive mechanisms in cancer and may be used against cancers that fail to respond to existing immunotherapy approaches. The antibodies — LYT-200 and LYT-210 — were developed to inhibit the Galectin-9 protein and gamma delta 1 (γδ1)…
This post was originally published on this site A recent study conducted by Johns Hopkins University indicates that caregivers aren’t nearly as susceptible to poor health as once believed, as providing care has no more significance on a caregiver’s immune system than any other job. For years, caregivers have seen studies that reached the opposite…
This post was originally published on this site Aiming to improve lenalidomide‘s safety and efficacy, ChemioCare is setting up to develop a new treatment formulation delivered through a skin patch, maintaining an optimal blood level of the medicine for prolonged periods of time. The new formulation uses the company’s permeation-enhanced transdermal technology (PETT), which “works like a…
